Resources

Past Presentation

Mealtime Insulin Therapy | February 8, 2024

Date of Presentation: February 8, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Diabetes ECHO Program  

Keywords: #diabetes  #ICR  #insulin  #mealtime  #prandial  #t1d  #t2d  #type 1  #type 2  

In this presentation, Dr. Carol Greenlee, endocrinologist, discusses mealtime insulin therapy for Type 1 and 2 Diabetes. Dr. Greenlee reviews this critical component of insulin therapy, its initiation, and optimal administration timing, as well as, the pathophysiology of postprandial hyperglycemia and estimating and utilizing an Insulin-to-Carbohydrate Ratio (ICR).

Recording:

Presented by:

Mary Carol Greenlee, MD, FACP, FACE

Mary Carol Greenlee, MD, FACP, FACE, is board-certified in Internal Medicine and Endocrinology, Diabetes and Metabolism and is in private practice at Western Slope Endocrinology in Grand Junction, Colorado. She is currently serving on the Endocrine Society Council after several years on the Society’s Clinical Affairs Core Committee. She has a special interest in care delivery issues and has been actively involved with the collaborative project sponsored by the Endocrine Society to develop tools to assist with the transition from pediatric to adult care for patients with endocrine disorders.

Resources Provided:

Date added: January 12, 2024